Notice of Agency Meeting, 66899-66900 [E8-26830]

Download as PDF Federal Register / Vol. 73, No. 219 / Wednesday, November 12, 2008 / Notices available on-line at http:// www.regulations.gov. As specified in FFDCA section 408(d)(3), (21 U.S.C. 346a(d)(3)), EPA is publishing notice of the petition so that the public has an opportunity to comment on this request for the establishment or modification of regulations for residues of pesticides in or on food commodities. Further information on the petition may be obtained through the petition summary referenced in this unit. A. New Exemption from a Tolerance 1. PP 8F7327. (EPA–HQ–OPP–2008– 0749). Isagro, S.p.A., Via Caldera 21, fabbricato D, la 3, Milano, Italy, proposes to establish an exemption from the requirement of a tolerance for residues of the fungicide, Trichoderma gamsii (strain ICC 080), in or on all food/feed commodities. Because this petition is a request for an exemption from the requirement of a tolerance without numerical limitations, no analytical method is required. Contact: Susanne Cerrelli, (703) 308–8077, cerrelli.susanne@epa.gov. 2. PP 8F7326. (EPA–HQ–OPP–2008– 0750). Isagro, S.p.A., Via Caldera 21, fabbricato D, la 3, Milano, Italy, proposes to establish an exemption from the requirement of a tolerance for residues of the fungicide, Trichoderma asperellum (strain ICC 012), in or on all food/feed commodities. Because this petition is a request for an exemption from the requirement of a tolerance without numerical limitations, no analytical method is required. Contact: Susanne Cerrelli, (703) 308–8077, cerrelli.susanne@epa.gov. B. Amendment to an Existing Tolerance 3. PP 8F7376. (EPA–HQ–OPP–2008– 0606). Luxembourg-Pamol, Inc., 5100 Poplar Ave., Suite 2700, Memphis, TN 38137, proposes to amend the tolerance in 40 CFR 180.1210 for residues of the fungicide, phosphorous acid and its ammonium, sodium, and potassium salts, in or on citrus at 35,600 parts per million (ppm). Contact: John Fournier, (703) 308–0169, fournier.john@epa.gov. mstockstill on PROD1PC66 with NOTICES List of Subjects Environmental protection, Agricultural commodities, Feed additives, Food additives, Pesticides and pests, Reporting and recordkeeping requirements. Dated: October 27, 2008. Janet L. Andersen, Director, Biopesticides and Pollution Prevention Division, Office of Pesticide Programs. [FR Doc. E8–26479 Filed 11–10–08; 8:45 am] Billing Code 6560–50–S VerDate Aug<31>2005 18:30 Nov 10, 2008 Jkt 217001 EQUAL EMPLOYMENT OPPORTUNITY COMMISSION Sunshine Act Meeting Equal Employment Opportunity Commission. DATE AND TIME: Thursday, November 20, 2008, 9:30 A.M. Eastern Time. PLACE: Clarence M. Mitchell, Jr. Conference Room on the Ninth Floor of the EEOC Office Building, 1801 ‘‘L’’ Street, NW., Washington, DC 20507. STATUS: The meeting will be open to the public. MATTERS TO BE CONSIDERED: AGENCY HOLDING THE MEETING: Open Session: 1. Announcement of Notation Votes, and 2. Employment Discrimination Against Individuals with Arrest and Conviction Records—Invited Experts. Note: In accordance with the Sunshine Act, the meeting will be open to public observation of the Commission’s deliberations and voting. (In addition to publishing notices on EEOC Commission meetings in the Federal Register, the Commission also provides a recorded announcement a full week in advance on future Commission sessions.) Please telephone (202) 663–7100 (voice) and (202) 663–4074 (TTY) at any time for information on these meetings. The EEOC provides sign language interpretation at Commission meetings for the hearing impaired. Requests for other reasonable accommodations may be made by using the voice and TTY numbers listed above. CONTACT PERSON FOR MORE INFORMATION: Stephen Llewellyn, Executive Officer on (202) 663–4070. Dated: November 6, 2008. This Notice Issued November 6, 2008. Stephen Llewellyn, Executive Officer, Executive Secretariat. [FR Doc. E8–26968 Filed 11–7–08; 4:15 pm] BILLING CODE 6570–01–P FEDERAL DEPOSIT INSURANCE CORPORATION Notice of Agency Meeting Pursuant to the provisions of the ‘‘Government in the Sunshine Act’’ (5 U.S.C. 552b), notice is hereby given that at 10:03 a.m. on Thursday, November 6, 2008, the Board of Directors of the Federal Deposit Insurance Corporation met in open session to consider the following matter: resolution re: Extension of Comment Period for Proposed Rules on the Risk Based Assessment System. PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 66899 In calling the meeting, the Board determined, on motion of Director Thomas J. Curry (Appointive), seconded by Vice Chairman Martin J. Gruenberg, concurred in by Director John M. Reich (Office of Thrift Supervision), Julie L. Williams, acting in the place and stead of Director John C. Dugan (Comptroller of the Currency), and Chairman Sheila C. Bair, that Corporation business required its consideration of the matter on less than seven days’ notice to the public; and that no earlier notice of the meeting was practicable. The meeting was held in the Board Room of the FDIC Building located at 550—17th Street, NW., Washington, DC. Dated: November 6, 2008. Federal Deposit Insurance Corporation. Robert E. Feldman, Executive Secretary. [FR Doc. E8–26829 Filed 11–10–08; 8:45 am] BILLING CODE 6714–01–P FEDERAL DEPOSIT INSURANCE CORPORATION Notice of Agency Meeting Pursuant to the provisions of the ‘‘Government in the Sunshine Act’’ (5 U.S.C. 552b), notice is hereby given that at 10:09 a.m. on Thursday, November 6, 2008, the Board of Directors of the Federal Deposit Insurance Corporation met in closed session to consider matters relating to the Corporation’s corporate and resolution activities. In calling the meeting, the Board determined, on motion of Vice Chairman Martin J. Gruenberg, seconded by Director Thomas J. Curry (Appointive), concurred in by Director John M. Reich (Director, Office of Thrift Supervision), Julie L. Williams, acting in the place and stead of Director John C. Dugan (Comptroller of the Currency), and Chairman Sheila C. Bair, that Corporation business required its consideration of the matters on less than seven days’ notice to the public; that no earlier notice of the meeting was practicable; that the public interest did not require consideration of the matters in a meeting open to public observation; and that the matters could be considered in a closed meeting by authority of subsections (c)(2), (c)(4), (c)(6), (c)(8), (c)(9)(A)(ii) and (c)(9)(B) of the ‘‘Government in the Sunshine Act’’ (5 U.S.C. 552b(c)(2), (c)(4), (c)(6), (c)(8), (c)(9)(A)(ii), and (c)(9)(B)). The meeting was held in the Board Room of the FDIC Building located at 550—17th Street, NW., Washington, DC. Dated: November 6, 2008. E:\FR\FM\12NON1.SGM 12NON1 66900 Federal Register / Vol. 73, No. 219 / Wednesday, November 12, 2008 / Notices Federal Deposit Insurance Corporation. Robert E. Feldman, Executive Secretary. [FR Doc. E8–26830 Filed 11–10–08; 8:45 am] percent of the voting shares of Citizens Bank, N.A., Abilene, Texas. BILLING CODE 6714–01–P Board of Governors of the Federal Reserve System, November 6, 2008. Jennifer J. Johnson, Secretary of the Board. [FR Doc. E8–26808 Filed 11–10–08; 8:45 am] FEDERAL RESERVE SYSTEM BILLING CODE 6210–01–S mstockstill on PROD1PC66 with NOTICES Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained from the National Information Center website at www.ffiec.gov/nic/. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than December 5, 2008. A. Federal Reserve Bank of St. Louis (Glenda Wilson, Community Affairs Officer) P.O. Box 442, St. Louis, Missouri 63166–2034: 1. Mt. Sterling Bancorp, Inc., Mt. Sterling, Illinois, to acquire 100 percent of the voting shares of Timewell State Bank, Timewell, Illinois. B. Federal Reserve Bank of Dallas (E. Ann Worthy, Vice President) 2200 North Pearl Street, Dallas, Texas 75201– 2272: 1. Big Country Bancshares, Inc., Abilene, Texas, to become a bank holding company by acquiring 100 VerDate Aug<31>2005 20:12 Nov 10, 2008 Jkt 217001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, Coordinating Center for Infectious Diseases (CCID) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: 9 a.m.–5 p.m., December 4, 2008. 8:30 a.m.–3:30 p.m., December 5, 2008. Place: CDC, Global Conference Center, Building 19, 1600 Clifton Road, NE., Atlanta, Georgia 30333. December 4, 2008—Building 19 (Work Groups meet). December 5, 2008—Auditorium B3 (Full Board meets). Status: Open to the public, limited only by the space available. Purpose: The Board of Scientific Counselors, CCID, provides advice and guidance to the Director, CDC, and Director, CCID, in the following areas: program goals and objectives; strategies; program organization and resources for infectious disease prevention and control; and program priorities. Matters to be Discussed: Agenda items will include: 1. Breakout Group Discussions: Vaccine Trust and Vaccine in Healthcare Workers (National Center for Preparedness, Detection, and Control of Infectious Diseases and National Center for Immunization and Respiratory Diseases). Discussion will be how reports, statements and recommendations of our established advisory committees (Advisory Council for the Elimination of Tuberculosis, CDC/HRSA Advisory Committee) can be presented to the Work Group and full committee most efficiently and effectively (National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, (NCHHSTP)). Program Collaboration and Service Integration (NCHHSTP) International Activities (National Center for Zoonotic, Vector-Borne, and Enteric Diseases, (NCZVED)). Peer Reviews and Planning and New Technology (NCZVED). 2. Antimicrobial Resistance (Full Board). 3. Budget and CCID/Office of the Director Updates (Full Board). Other agenda items include announcements, introductions, and follow- PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 up on actions recommended by the board, directions, goals, and recommendations. Agenda items are subject to change as priorities dictate. Written comments are welcome and should be received by the contact person listed below prior to the opening of the meeting. Contact Person for More Information: Harriette Lynch, Office of the Director, CCID, CDC, Mailstop E–77, 1600 Clifton Road, NE., Atlanta, Georgia 30333, Telephone: (404)498–2726, e-mail: hlynch@cdc.gov. The Director, Management Analysis and Services office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the CDC and the Agency for Toxic Substances and Disease Registry. Dated: November 4, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–26795 Filed 11–10–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Health Marketing (BSC, NCHM) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), CDC announces the following meeting of the aforementioned committee: Times and Dates: 9 a.m.–4:30 p.m., December 8, 2008. 9 a.m.–3 p.m., December 9, 2008. Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton Road, NE., Building 21, Auditorium A (Room 1204A), Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 60 people. Purpose: The Secretary, Department of Health and Human Services (HHS), and, by delegation, the Director, Centers for Disease Control and Prevention (CDC), are authorized under Section 301 (42 U.S.C. 241) and Section 311 (42 U.S.C. 243) of the Public Health Service Act (PHSA), as amended to: develop and implement disease prevention and control, environmental health, and health promotion and health education activities designed to improve the health of the people of the United States. Under these and additional PHSA and other authorities, CDC acts by identifying and defining preventable health problems; maintaining active surveillance of diseases through epidemiologic and laboratory investigations and data collection, analysis, and distribution; conducting operational research aimed at developing and testing effective disease prevention, control, and health E:\FR\FM\12NON1.SGM 12NON1

Agencies

[Federal Register Volume 73, Number 219 (Wednesday, November 12, 2008)]
[Notices]
[Pages 66899-66900]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-26830]


-----------------------------------------------------------------------

FEDERAL DEPOSIT INSURANCE CORPORATION


Notice of Agency Meeting

    Pursuant to the provisions of the ``Government in the Sunshine 
Act'' (5 U.S.C. 552b), notice is hereby given that at 10:09 a.m. on 
Thursday, November 6, 2008, the Board of Directors of the Federal 
Deposit Insurance Corporation met in closed session to consider matters 
relating to the Corporation's corporate and resolution activities.
    In calling the meeting, the Board determined, on motion of Vice 
Chairman Martin J. Gruenberg, seconded by Director Thomas J. Curry 
(Appointive), concurred in by Director John M. Reich (Director, Office 
of Thrift Supervision), Julie L. Williams, acting in the place and 
stead of Director John C. Dugan (Comptroller of the Currency), and 
Chairman Sheila C. Bair, that Corporation business required its 
consideration of the matters on less than seven days' notice to the 
public; that no earlier notice of the meeting was practicable; that the 
public interest did not require consideration of the matters in a 
meeting open to public observation; and that the matters could be 
considered in a closed meeting by authority of subsections (c)(2), 
(c)(4), (c)(6), (c)(8), (c)(9)(A)(ii) and (c)(9)(B) of the ``Government 
in the Sunshine Act'' (5 U.S.C. 552b(c)(2), (c)(4), (c)(6), (c)(8), 
(c)(9)(A)(ii), and (c)(9)(B)).
    The meeting was held in the Board Room of the FDIC Building located 
at 550--17th Street, NW., Washington, DC.

    Dated: November 6, 2008.


[[Page 66900]]


Federal Deposit Insurance Corporation.
Robert E. Feldman,
Executive Secretary.
 [FR Doc. E8-26830 Filed 11-10-08; 8:45 am]
BILLING CODE 6714-01-P